Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04197336 · ClinicalTrials.gov registry record · NA
Bariatric Embolization of Arteries With Imaging Visible Embolics (BEATLES)
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04197336: Completed NA study, sponsored by Johns Hopkins University.
NCT04197336 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04197336, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The BEATLES study is an investigator-initiated, prospective, double-blinded, randomized, sham-controlled study that will assess the impact of bariatric embolization on the systemic levels of obesity-related hormones and, as a consequence, on weight loss. The goal of this study is to help treat obesity combining a lifestyle program and a minimally invasive, angiographic (i.e., through blood vessels) approach.
Interventions
- DEVICE Bariatric Embolization of Arteries with imaging visible Embolics
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2020-01-10 |
| Est. Completion | 2023-12-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04197336
The ClinicalTrials.gov registry entry for NCT04197336 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bariatric Embolization of Arteries with imaging visible Embolics is the first listed.
NCT04197336 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04197336 about?
NCT04197336 is a clinical study titled "Bariatric Embolization of Arteries With Imaging Visible Embolics (BEATLES)". The BEATLES study is an investigator-initiated, prospective, double-blinded, randomized, sham-controlled study that will assess the impact of bariatric embolization on the systemic levels of obesity-related hormones and, as a consequence, on weight loss. The goal of this study is to help treat obesi...
What is the current status of trial NCT04197336?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2020-01-10. Estimated completion is 2023-12-14.
What interventions are being tested in trial NCT04197336?
The interventions under investigation include: Bariatric Embolization of Arteries with imaging visible Embolics (DEVICE).
Who is sponsoring clinical trial NCT04197336?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.